Results 51 to 60 of about 2,098 (173)
Adult-onset Still’s disease (AOSD) is a multi-systemic inflammatory disorder of unknown etiology. To date, no single diagnostic test is available for AOSD. Herein, we investigated the pathogenic role of microRNAs in AOSD. MicroRNA profiles in plasma from
Tsai-Ling Liao +7 more
doaj +1 more source
Pathogenesis, disease course, and prognosis of adult-onset Still's disease: an update and review
. Objective:. Adult-onset Still's disease (AOSD) is a rare but clinically well-known polygenic systemic autoinflammatory disease. In this review, we aim to present frontiers in the pathogenesis, clinical features, diagnosis, biomarkers, disease course ...
Meng-Yan Wang +4 more
doaj +1 more source
ABSTRACT This update and revision of the international guideline for urticaria was developed in accordance with the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. It is an initiative of the Global Allergy and Asthma Excellence Network (GA2LEN) and its Urticaria and ...
Torsten Zuberbier +221 more
wiley +1 more source
Metabolic Disturbances in Adult-Onset Still's Disease Evaluated Using Liquid Chromatography/Mass Spectrometry-Based Metabolomic Analysis. [PDF]
Liquid chromatography/mass spectrometry (LC/MS)-based comprehensive analysis of metabolic profiles with metabolomics approach has potential diagnostic and predictive implications.
Der-Yuan Chen +7 more
doaj +1 more source
A total of 140 Kikuchi‐Fujimoto disease (KFD) patients were included (ANA positivity 62.1%), of whom 10 had concurrent rheumatic diseases. Among the remaining 130 patients without rheumatic diseases, other autoantibodies were detected in 11.5% of ANA‐positive patients. After a median follow‐up of 39 months, the relapse rate was 5.6% (6/107).
Xia Zhang, Rui Yan, Yanying Liu
wiley +1 more source
ABSTRACT This retrospective cohort study aimed to identify clinical and laboratory predictors of relapse in patients with Still's disease. A total of 94 patients diagnosed by Yamaguchi or Fautrel criteria across two rheumatology centers between 2012 and 2024 were evaluated, of whom 87 were eligible for analysis.
İbrahim Yahya Çakır +12 more
wiley +1 more source
Objective This systematic review documents the current status of extracorporeal membrane oxygenation (ECMO) use in patients with complications of rheumatologic diseases. Methods Following Preferred Reporting Items for Systematic Reviews and Meta Analyses 2020 guidelines, we conducted a systematic review of studies published from January 2019 to ...
Kari L. Falaas +3 more
wiley +1 more source
Extracellular Vesicles in Autoimmune Diseases: From Diagnostic Biomarkers to Engineered Therapeutics
This review provides a systematic comparison of extracellular vesicles (EVs) from both mammalian and plant sources in the context of autoimmune diseases. It highlights their emerging roles as precision biomarkers and engineered therapeutic platforms.
Yufei Wu +6 more
wiley +1 more source
Disentangling crosscutting in AOSD: formalization based on a crosscutting pattern [PDF]
Crosscutting is usually described in terms of scattering and tangling. However, the distinction between these concepts is vague, which could lead to ambiguous statements. Sometimes, precise definitions are required, e.g., for the formal identification of crosscutting concerns.
J. M. Conejero, K. G. van den Berg
openaire +1 more source
Background Adult-onset Still’s disease (AOSD) is a systemic inflammatory disease characterized by neutrophilia and NLRP3 inflammasome and macrophage activation. We investigated the role of neutrophil extracellular traps (NETs) in the pathogenesis of AOSD,
Qiongyi Hu +16 more
doaj +1 more source

